Genentech
Genentech, OSI to pay $67 mn to settle false claims on cancer drug Tarceva
08 June 2016
23andMe Inc, Genentech to analyse genomes of 3,000 Parkinson’s patients
09 January 2015
Genentech to pay up to $1.7 bn for oncology firm Seragon
03 July 2014
GSK sues Roche over Genentech's cancer drug patent infringement
23 September 2010
Genentech pulls drug from US market after health scare
09 April 2009
Roche clinches Genentech deal for $47 billion
12 March 2009
Roche calls Genentech’s $112 a share demand unreasonable, may reach agreement on $95 a share
10 March 2009
Roche raises Genentech offer from $86.50 to $93 a share
07 March 2009
Genentech tells shareholders to reject Roche bid
24 February 2009
Sale of Genentech skin drug `Raptiva' suspended after 3 deaths
20 February 2009
Genentech Submits application to US FDA for avastin for brain cancer treatment
04 November 2008
Roche confirms plans to acquire remaining 44 per cent in Genentech
21 October 2008
Credit squeeze takes its toll on Xstrata, Roche acquisition bids
03 October 2008
Genentech Says Employee Plan May Cost $371 Million
23 August 2008
Genentech rejects Roche’s $43.7-billion takeover offer as too low
13 August 2008
Roche bids for Genentech on Monday, acquires Mirus on Tuesday and Arius on Wednesday
25 July 2008
Roche makes a $43.7-billion bid for Genentech
21 July 2008
US FDA panel rejects the use of Genentech’s Avastin for breast cancer
07 December 2007
TCS to support Roche's global capacity building initiative
05 September 2007
Genentech to set up new facility in Singapore
28 March 2007
 search domain-b
  go